Green Cell Technologies

Green Cell Technologies is a biotechnology firm headquartered in the Isle of Man, with a research facility in Cape Town, South Africa. Founded in 2011 by Roy Henderson, a retired South African Navy officer, and Jan Vlok, the company develops and commercializes Dynamic Cellular Disruption (DCD), a mechanical process designed to rupture plant and other biological cell structures without relying on solvents or high heat. The technology is implemented through specialized Disruptor machines. By mechanically opening cellular structures in biomass, the process is intended to make compounds more accessible for extraction and downstream use while helping preserve characteristics that may be affected by conventional high-temperature processing. Reported application areas include food ingredients, agricultural materials, nutraceutical extracts, seaweed processing, beverage bases, and other industrial biological materials. The origins of the technology predate the company. A project conducted in 2007 and 2008 focused on extracting compounds from orange peel and contributed to the development of the DCD approach. Green Cell Technologies was subsequently established in 2011 to develop the technology and pursue commercial applications. The company has pursued partnerships and licensing arrangements rather than positioning itself solely as a consumer-facing product brand. In 2018, it entered a global licensing agreement with citrus processor Citrosuco. The agreement connected Green Cell Technologies' processing platform with a major citrus-industry participant and represented an effort to expand the technology's industrial deployment. Reported applications have included the processing of citrus-related materials, although the available reference material does not provide detailed commercial performance figures or the agreement's financial terms. Green Cell Technologies has also explored applications beyond citrus. Trade coverage has associated its DCD process with nutraceutical extraction, increasing the protein content or usable value of seaweed, and the creation of ingredient bases for beverages. In 2023, the company partnered with Molecular Health Technologies for distribution of a kanna extract produced using the DCD method. This partnership illustrates the platform's potential use in botanical and nutraceutical ingredients, but the available material does not establish the product's sales scale, geographic reach, or long-term commercial outcome. The company's public profile is primarily technology- and business-to-business-oriented. It supplies or licenses a processing method and related equipment rather than presenting a broad portfolio of branded packaged goods. Information available in the supplied reference material does not establish a current chief executive, ownership structure, listing status, annual revenue, workforce size, or definitive global market footprint. Its documented base in the Isle of Man and research presence in Cape Town indicate an international operating structure focused on developing and applying mechanical cell-disruption technology across food, agricultural, nutraceutical, and industrial sectors.

Green Cell Technologies developed from a 2007–2008 project focused on extracting compounds from orange peel. The project helped establish the foundations of Dynamic Cellular Disruption, a mechanical processing approach intended to open biological cells without solvents or high heat. The method uses specialized Disruptor machines to rupture cellular structures in biomass and make target compounds more accessible for extraction or further processing. Roy Henderson, a retired South African Navy officer, and Jan Vlok founded Green Cell Technologies in 2011. The company was established to develop the technology for commercial use and to apply it across food, agricultural, nutraceutical, and industrial processing. It is headquartered in the Isle of Man and operates a research facility in Cape Town, South Africa, giving the company a cross-border structure linked to both technology development and application work. The platform's reported uses expanded beyond its initial citrus-related origins. Applications have included nutraceutical extracts, seaweed processing intended to increase the material's protein content or usability, and the preparation of ingredient bases for beverages. These applications position the company as a technology provider and licensing partner rather than primarily as a consumer packaged-goods manufacturer. In 2018, Green Cell Technologies entered a global licensing agreement with Citrosuco, a major citrus processor. The arrangement was an important commercial development because it connected the DCD platform with an established industrial citrus business and provided a route for broader deployment. The supplied reference material does not disclose the agreement's value, detailed territory terms, or measured commercial results. In 2023, Green Cell Technologies partnered with Molecular Health Technologies to distribute a kanna extract made using the DCD method. The partnership demonstrated continued expansion into botanical and nutraceutical ingredients. No reliable information in the supplied material establishes the scale of distribution, current management, ownership, revenues, or whether particular applications remain in active commercial production. Green Cell Technologies' documented history is therefore centered on the development of a mechanical cell-disruption platform, its movement from an orange-peel research project into a formal company, and partnerships intended to apply the technology in citrus, nutraceutical, seaweed, beverage, and related biological-material markets.

• 2023

  Kanna-extract distribution partnership

  [1]Green Cell Technologiesen.wikipedia.org

  Green Cell Technologies partnered with Molecular Health Technologies to distribute a kanna extract produced using DCD.

• 2018

  Global Citrosuco licensing agreement

  [1]Green Cell Technologiesen.wikipedia.org

  The company entered a global licensing agreement with citrus processor Citrosuco.

• 2011

  Green Cell Technologies founded

  [1]Green Cell Technologiesen.wikipedia.org

  Roy Henderson and Jan Vlok founded Green Cell Technologies to develop and commercialize the DCD platform.

• 2008

  Early DCD development work

  [1]Green Cell Technologiesen.wikipedia.org

  Work during 2007–2008 contributed to the development of a mechanical method for disrupting cells in biomass without solvents or high heat.

• 2007

  Orange-peel extraction project begins

  [1]Green Cell Technologiesen.wikipedia.org

  A project focused on extracting compounds from orange peel provided the early technical basis for the later Dynamic Cellular Disruption process.

A business-to-business biotechnology and processing platform focused on solvent-free, low-heat mechanical disruption of biological cells for extraction and ingredient development.

• Biomass-processing technology

  Dynamic Cellular Disruption

  Dynamic Cellular Disruption, or DCD, is Green Cell Technologies' core mechanical processing method. It uses specialized equipment to rupture cell structures in biomass without solvents or high heat. The resulting disruption is intended to facilitate extraction of compounds and preparation of biological materials for food, agricultural, nutraceutical, beverage, and industrial uses.

• Industrial processing equipment

  Disruptor machines

  Disruptor machines are the equipment platform associated with the DCD process. They mechanically process biological feedstocks so that cellular structures are opened and their contents become more accessible. The available reference material does not specify individual machine models, capacities, prices, or current production status.

• Botanical and nutraceutical ingredient · 2023

  Kanna extract

  A kanna extract produced using Green Cell Technologies' DCD method was the subject of a 2023 distribution partnership with Molecular Health Technologies. The available sources identify the processing method and distribution relationship but do not provide a detailed formulation, product specification, or sales footprint.

• 2023Kanna extract distribution partnership

  Botanical ingredients · Nutraceuticals

  The company partnered with Molecular Health Technologies on distribution of a kanna extract made with the DCD process.

  Outcome. The partnership expanded the documented application of DCD into botanical extraction; no further commercial outcome is reported in the supplied sources.

  Source
• 2018Citrosuco global licensing partnership

  Citrus processing · Global industrial markets

  Green Cell Technologies pursued international commercialization of its DCD platform through a global licensing agreement with Citrosuco, linking the technology to citrus-processing operations.

  Outcome. The available reference confirms the agreement but does not report its financial results, implementation scale, or subsequent performance.

  Source

• 2023

  Expand DCD applications into kanna extract distributionStrategy

  Background

  The company continued applying its processing platform beyond citrus and broader biomass uses.

  Action taken

  Green Cell Technologies partnered with Molecular Health Technologies to distribute a DCD-produced kanna extract.

  Aftermath

  The partnership documented a further move into botanical and nutraceutical ingredients; detailed commercial results are not available.

  Source

• 2018

  Enter a global licensing agreement with CitrosucoM&A

  Background

  Green Cell Technologies sought a route to apply its DCD technology at industrial scale in the citrus sector.

  Action taken

  The company entered a global licensing agreement with Citrosuco.

  Aftermath

  The agreement established a documented commercial relationship with a major citrus processor, but the available sources do not provide financial or operational results.

  Source

1. 1Green Cell Technologiesen.wikipedia.org